Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Sciencex was a French pharmaceutical company specializing in the development and commercialization of products for venous circulation and dermatology. The company is most notably recognized for its flagship product, Ginkor Fort, a widely used treatment for venous insufficiency and hemorrhoidal symptoms based on Ginkgo biloba extract. In 1994, the laboratory was acquired by Tonipharm from the Ipsen Group, which continues to market several of the Sciencex legacy brands. Today, the entity's portfolio remains a core part of Tonipharm's offerings, focusing on over-the-counter (OTC) and prescription solutions for vascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Sciencex.